Literature DB >> 170096

Nuclear protein-kinase activity in perfused rat liver stimulated with dibutyryl-adenosine cyclic 3':5'-monophosphate.

M Castagna, W K Palmer, D A Walsh.   

Abstract

Cytoplasmic and nuclear protein kinase activities from perfused rat liver have been studied in response to dibutyryl-adenosine cyclic 3':5'-monophosphate added at a concentration that stimulates hepatic gluconeogenesis (100 muM). Total nuclear protein kinase, as assayed using a mixed histone fraction as phosphate acceptor, is increased by 5-fold within 8 min of the addition of cyclic nucleotide to the perfusate. In contrast the total cytoplasmic protein kinase activity is decreased to 50% of the control value. The protein substrate specificity of the protein kinase that is present in the nucleus in response to dibutyryl-adenosine cyclic 3':5'-monophosphate stimulation is similar to that of cytoplasmic, adenosine cyclic 3':5'-monophosphate-dependent, protein kinase but is distinct from that of the enzyme(s) present in control nuclei. The predominant species to protein kinase from stimulated nuclei has a sedimentation constant of 3.9 S. This value is identical to that of the catalytic subunit of cytoplasmic adenosine 3':5'-monophosphate-dependent protein kinase. These data suggest that some of the effects of adenosine 3':5'-monophosphate on nuclear events may be mediated through its interaction with the inactive protein kinase holoenzyme in the cytoplasm and the subsequent redistribution of the active catalytic subunits generated by this interaction.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 170096     DOI: 10.1111/j.1432-1033.1975.tb02151.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  10 in total

1.  Cyclic AMP-dependent histone-specific nucleoplasmic protein kinase from rat liver.

Authors:  J R Neumann; A R O'Meara; R L Herrmann
Journal:  Biochem J       Date:  1978-04-01       Impact factor: 3.857

2.  In vivo phosphorylation of a synthetic peptide substrate of cyclic AMP-dependent protein kinase.

Authors:  J L Maller; B E Kemp; E G Krebs
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

3.  Cyclic nucleotide-binding proteins detected by photoaffinity labeling in nucleus and cytoplasm of bovine liver.

Authors:  D L Friedman; D A Chambers
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

4.  Activation and nuclear translocation of protein kinase during transsynaptic induction of tyrosine 3-monooxygenase.

Authors:  E Costa; A Kurosawa; A Guidotti
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

5.  Effects of radioprotectors on the cAMP and cGMP systems.

Authors:  A S Sobolev; V V Tertov; A R Kazarov
Journal:  Radiat Environ Biophys       Date:  1984       Impact factor: 1.925

Review 6.  Nuclear protein kinases.

Authors:  H R Matthews; V D Huebner
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

7.  Adenylate cyclase activity in lymphocyte subcellular fractions. Characterization of a nuclear adenylate cyclase.

Authors:  H J Wedner; C W Parker
Journal:  Biochem J       Date:  1977-03-15       Impact factor: 3.857

8.  Specific nuclear binding of adenosine 3',5'-monophosphate-binding protein complex with subsequent poly(A) RNA synthesis in embryonic chick cartilage.

Authors:  W M Burch; H E Lebovitz
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

9.  Rapid and reversible translocation of the catalytic subunit of cAMP-dependent protein kinase type II from the Golgi complex to the nucleus.

Authors:  E A Nigg; H Hilz; H M Eppenberger; F Dutly
Journal:  EMBO J       Date:  1985-11       Impact factor: 11.598

10.  Direct cytochemical localization of catalytic subunits dissociated from cAMP-dependent protein kinase in Reuber H-35 hepatoma cells. II. Temporal and spatial kinetics.

Authors:  C V Byus; W H Fletcher
Journal:  J Cell Biol       Date:  1982-06       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.